MKI67 and autoimmune disease: Of the two misclassified patients, one had increased expression of all inflammatory markers, high Ki-67 expression and impaired Treg function, and therefore had a high 67.6% prediction for need for sarcoid therapy, but this patient was on immunosuppression for autoimmune disease (#10, Table 1).